Skip to content

Efficacy of Intermittent Quadriceps Blood Flow Restriction Training in Female College Students with Patellofemoral Pain Syndrome

Efficacy of Intermittent Quadriceps Blood Flow Restriction Training in Female College Students with Patellofemoral Pain Syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600123757
Enrollment
Unknown
Registered
2026-04-29
Start date
2026-04-30
Completion date
Unknown
Last updated
2026-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patellofemoral Pain Syndrome

Interventions

intermittent blood flow restriction training group:The intervention period for this study was 6 weeks. Participants in each group trained twice a week, with each session lasting approximately 40 minut
high-intensity resistance training group:Like the intervention group, the entire program was divided into four phases: warm-up, standard rehabilitation exercises, high-intensity resistance training fo

Sponsors

Beijing Sport University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 25 Years

Inclusion criteria

Inclusion criteria: 1. Presence of unilateral retropatellar or peripatellar pain not caused by trauma; 2. Pain VAS >= 3 cm, persisting for over 8 weeks; 3. Pain reproducible during two or more functional activities: squatting, jumping, prolonged sitting, kneeling, stair climbing, walking, or running; 4. Other potential causes of anterior knee pain have been ruled out.

Exclusion criteria

Exclusion criteria: 1. History of patellar dislocation, subluxation, cartilage damage, ligament laxity, or other knee joint injuries; 2. Other knee joint pathologies, such as knee osteoarthritis, tibial tubercle osteochondrosis, patellar tendon disorders, iliotibial band syndrome, or other tendon pathologies; 3. Previous knee surgery or arthritis; 4. Any invasive procedure involving the intervention knee within the past 12 months, such as arthroscopy or intra-articular injections; 5. Physical therapy or exercise therapy interventions targeting the intervention knee within the past 6 months; 6. Nonsteroidal anti-inflammatory drug (NSAID) treatment within the past 3 months; 7. Any neurological, cardiac, or vascular disease, such as coagulation disorders; 8. Other acute, chronic, or psychiatric conditions affecting physical or cognitive function; 9. Pregnancy.

Design outcomes

Primary

MeasureTime frame
visual analog scale (VAS);knee pain scales (AKPS);Lysholm scale;

Secondary

MeasureTime frame
peak knee extension moments at 60°/s and 120°/s angular velocities;quadriceps muscle thickness;Y-balance test;electrophysiological indicators maximal isometric contractions of quadriceps;

Countries

China

Contacts

Public ContactZixi Han

Beijing Sport University

1342536073@qq.com+86 151 2352 7184

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 7, 2026